Cycling, doping & the importance of due process: A review of the Karl Murray case
In a decision1 dated 13 October 2017, a Panel from Sports Tribunal of New Zealand found cyclist Karl Murray liable for committing an anti-doping rule violation. Murray was competing in the Tour of Northland when he tested positive for Clenbuterol2 in a sample provided on 18 March 2017.
This article reviews the Tribunal’s decision, looking specifically at:
-
The facts of the case;
-
The relevant regulations, namely the Board of Drug Free Sport New Zealand Sports Anti-Doping Rules (2017);3
-
The Court’s reasoning and decision;
-
Why the sanction has been postponed.
Continue reading this article...
Register with your email and password
Already a member? Sign in
Get access to all of the expert analysis and commentary at LawInSport including articles, webinars, conference videos and podcast transcripts. Find out more here.
- Tags: Anti-Doping | Board of Drug Free Sport New Zealand | Cycling | New Zealand | Prohibited List | WADA Code 2015 | WADA International Standard for Testing and Investigations (ISTI) | World Anti-Doping Agency (WADA)
Related Articles
- U.S. Volleyball Athlete Alexandra Klineman Accepts Finding of No Fault for Anti-Doping Rule Violation
- Powerful partnership to tackle improper PED prescriptions
- UK Anti-Doping Releases Findings into its Cycling Investigation
About the Author
Ani Ghazikhanian
Ani Ghazikhanian is a staff attorney at Jones Day and guides clients in the resolution of commercial disputes in business and tort litigation. She currently works on the representation of Experian, one of the three national consumer credit reporting agencies, in individual consumer credit litigation brought under the Fair Credit Reporting Act.
Prior to joining Jones Day in 2019, Ani served as a legal intern with the Minnesota Vikings Football organization as well as with LawInSport, a leading online international sports law publication.